ArticleOncology letters2024

Quality of life assessment and cost‑utility analysis of initial chemotherapy for patients with non‑Hodgkin's lymphoma: A prospective analysis.

Kazuhide Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.